clinical trial · NCT04640831
Safety of GH001 in Healthy Volunteers
GH Research Ireland Limited·phase1·completed·n = 22
Healthy Volunteers5 Methoxy N,N Dimethyltryptamine
brief summary
The aim of the study is to investigate the safety of GH001 (containing 5-methoxy-dimethyltryptamine; 5-MeO-DMT), and its dose-related psychoactive effects in healthy volunteers. The study will evaluate single, ascending doses of GH001 in Part A and an individualized dosing regimen of GH001 in Part B.
started
Mar 13, 2019
primary completion
Oct 4, 2019
completion
Oct 4, 2019
last updated
Aug 15, 2023
official title
A Phase 1 Dose-ranging Study of GH001 in Healthy Volunteers
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol